Skip to content
AwardedCyprusGoods€2,886,047

Προσφορά για την προμήθεια Avapritinib, Enfortumab και Gilteritinib, Αρ. Διαγωνισμού: Φ.Υ.Υ. 41/2025 (YY), Αρ.Φακ. Φ.Υ.Υ.13.25.02.08.221

Published
Published 18 March 2025
Deadline
Closed 17 April 2025

Overview

Προμήθεια Avapritinib, Enfortumab και Gilteritinib, Αρ. Διαγωνισμού: Φ.Υ.Υ. 41/2025 (YY), Αρ.Φακ. Φ.Υ.Υ.13.25.02.08.221

Key details

Country
Cyprus
Status
Awarded
Category
Goods
Estimated value
€2,886,047
Procedure
Open
SME suitable
Yes
Published
18 March 2025
Deadline
Closed
Classification (CPV)
Antineoplastic agents

Award outcome

Awarded value
€2,907,620
Award date
22 May 2025
Winner
  • Novagem Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    3 June 2025

  2. Contract Notice

    18 March 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Προσφορά για την προμήθεια Avapritinib, Enfortumab και Gilteritinib, Αρ. Διαγωνισμού: Φ.Υ.Υ. 41/2025 (YY), Αρ.Φακ. Φ.Υ.Υ.13.25.02.08.221 — won by Novagem Ltd — Skim